Drug profile · INN
terbutaline sulfate
TERBUTALINE SULFATE
terbutaline sulfate (TERBUTALINE SULFATE) is a beta-2 adrenergic receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — terbutaline sulfate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
terbutaline sulfate (TERBUTALINE SULFATE) is a beta-2 adrenergic receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-2 adrenergic receptor agonist
Primary target: Beta-2 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is terbutaline sulfate?
terbutaline sulfate (TERBUTALINE SULFATE) is a beta-2 adrenergic receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for terbutaline sulfate?
TERBUTALINE SULFATE is a marketed brand name for terbutaline sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of terbutaline sulfate?
terbutaline sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.